Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000034

CEO bought 181,000 shares at an average $0.01 ($1,725)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-24 Purchase : show line 1 in the form +29,800 $0.01 $283 23,324,397 D
2019-05-24 Purchase : show line 2 in the form +20,200 $0.01 $190 23,344,597 D
2019-05-24 Purchase : show line 3 in the form +20,000 $0.01 $188 23,364,597 D
2019-05-24 Purchase : show line 4 in the form +10,000 $0.01 $100 23,374,597 D
2019-05-24 Purchase : show line 5 in the form +10,000 $0.01 $98 23,384,597 D
2019-05-24 Purchase : show line 6 in the form +20,000 $0.01 $192 23,404,597 D
2019-05-24 Purchase : show line 7 in the form +20,000 $0.01 $190 23,424,597 D
2019-05-24 Purchase : show line 8 in the form +1,000 $0.01 $10 23,425,597 D
Open-market purchases · 181,000 sh · avg $0.01 · $1,725
Loading xslF345X03/primary_doc.xml…